Aspirin is associated with a reduced risk of colorectal cancer, which has led to the suggestion of a similar protective role in urological cancers. Bosetti et al. have examined all the available epidemiological data to assess if a relationship exists between aspirin use and cancers of the prostate, bladder and kidney.